SCHEMBL11933622

SCHEMBL11933622

Cc1ccc2ccccc2c1-c1cc2ccccc2[n+](C)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.41
▸ CYP2A6 P11509 3/20 0.41
▸ TSHR P16473 2/20 0.41
▸ TERT O14746 2/20 0.39
▸ ALDH1A1 P00352 3/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ JAK2 O60674 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ RAD52 P43351 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ BLM P54132 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ ACHE P22303 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ GRIN2D O15399 1/20 0.35
▸ GRIN3B O60391 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11933620 0.81 TERT (0.41) CYP1A2CYP2A6TERTALDH1A1KMT2A
SCHEMBL11933621 0.76 CA12 (0.44) TERTGAARAB9A
SCHEMBL30379142 0.74 CYP1A2 (0.48) CYP1A2CYP2A6TSHRALDH1A1MAPT
SCHEMBL6310662 0.73 TSHR (0.56) CYP1A2CYP2A6TSHRALDH1A1MAPT
SCHEMBL25518755 0.72 CYP1A2 (0.43) CYP1A2CYP2A6TSHRALDH1A1MAPT
SCHEMBL29352216 0.72 TSHR (0.65) CYP1A2CYP2A6TSHRALDH1A1MAPT
SCHEMBL2951616 0.72 TSHR (0.65) CYP1A2CYP2A6TSHRALDH1A1MAPT
Ammonia Solution, Strong SCHEMBL27919131 0.71 TSHR (0.54) CYP1A2CYP2A6TSHRALDH1A1MAPT
SCHEMBL20404983 0.70 HPRT1 (0.48) CYP1A2CYP2A6TSHRALDH1A1KMT2A
SCHEMBL12075034 0.70 TERT (0.43) TERTKMT2AMEN1RAB9AACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230264181-A1 RADICAL GENERATING CATALYST, METHOD FOR PRODUCING RADICAL, METHOD FOR PRODUCING OXIDATION REACTION PRODUCT, DRUG, AND DRUG FOR AGRICULTURE AND LIVESTOCK ACENET INC (JP) 2023-08-24 — — US disclosed
US-11673129-B2 Radical generating catalyst, method for producing radical, method for producing oxidation reaction product, drug, and drug for agriculture and livestock ACENET INC. (JP) 2023-06-13 — — US disclosed
EP-2479160-B1 PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND UNIV OSAKA (JP) 2015-09-09 — — EP disclosed
US-20120171111-A1 PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND OSAKA UNIVERSITY (JP) 2012-07-05 — — US disclosed
US-7977486-B2 Quinolinium ion derivatives, process for the production of the derivatives, products made by using the same, and reduction and oxidation methods with the derivatives OSAKA UNIVERSITY (JP) 2011-07-12 — — US disclosed
US-7977486-B2 Quinolinium ion derivatives, process for the production of the derivatives, products made by using the same, and reduction and oxidation methods with the derivatives OSAKA UNIVERSITY (JP) 2011-07-12 — — US disclosed
WO-2011034071-A1 PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND 国立大学法人大阪大学 (JP) 2011-03-24 — — WO disclosed
US-20100004454-A1 QUINOLINIUM ION DERIVATIVES, PROCESS FOR THE PRODUCTION OF THE DERIVATIVES, PRODUCTS MADE BY USING THE SAME, AND REDUCTION AND OXIDATION METHODS WITH THE DERIVATIVES OSAKA UNIVERSITY (JP) 2010-01-07 — — US disclosed
US-20100004454-A1 QUINOLINIUM ION DERIVATIVES, PROCESS FOR THE PRODUCTION OF THE DERIVATIVES, PRODUCTS MADE BY USING THE SAME, AND REDUCTION AND OXIDATION METHODS WITH THE DERIVATIVES OSAKA UNIVERSITY (JP) 2010-01-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230264181-A1 RADICAL GENERATING CATALYST, METHOD FOR PRODUCING RADICAL, METHOD FOR PRODUCING OXIDATION REACTION PRODUCT, DRUG, AND DRUG FOR AGRICULTURE AND LIVESTOCK LPO, CAT, NOX4 CYP1A2 70/4885CYP2A6 92/4885TSHR 595/4885
US-20120171111-A1 PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND TYR, AOX1, POR CYP1A2 90/4885CYP2A6 427/4885TSHR 4382/4885
US-20100004454-A1 QUINOLINIUM ION DERIVATIVES, PROCESS FOR THE PRODUCTION OF THE DERIVATIVES, PRODUCTS MADE BY USING THE SAME, AND REDUCTION AND OXIDATION METHODS WITH THE DERIVATIVES APEX1, NQO1, POT1 CYP1A2 2589/4885CYP2A6 4231/4885TSHR 4416/4885
US-11673129-B2 Radical generating catalyst, method for producing radical, method for producing oxidation reaction product, drug, and drug for agriculture and livestock LPO, CAT, NOX4 CYP1A2 70/4885CYP2A6 92/4885TSHR 595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback